Apyx Medical (APYX) vs SkinHealth Systems (SKIN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
SkinHealth Systems (SKIN) has outperformed Apyx Medical (APYX) over the past year, gaining 791.7% versus a loss of 40.0%. Over five years, SKIN leads with a -57.1% price change compared with -83.4% for APYX. Apyx Medical is the larger company by market cap ($101.1 million vs $76.7 million), about 1.3 times the size.
SkinHealth Systems converts more of its revenue into profit, with a net margin of -3.2% versus -21.2%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | APYX | SKIN |
|---|---|---|
| Share price | $2.40 | $11.77 |
| Market cap | $101.10M | $76.68M |
| 1-day change | +0.42% | -3.13% |
| YTD return | -31.43% | +746.76% |
| 1-year return | -40.00% | +791.67% |
| 5-year return | -83.40% | -57.11% |
| Forward P/E | — | 2.63 |
| EPS (TTM) | $-0.19 | $-2.98 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $52.84M | $300.79M |
| Revenue growth (YoY) | +9.86% | -10.02% |
| Net income (latest FY) | $-11.21M | $-9.52M |
| Gross margin | 62.53% | 65.28% |
| Operating margin | -12.20% | -6.92% |
| Net margin | -21.22% | -3.16% |
| 52-week high | $5.08 | $33.00 |
| 52-week low | $2.25 | $9.68 |
| Distance from 52-week high | -52.76% | -64.33% |
| Analyst consensus | strong_buy | hold |
| Avg. price target upside | +170.83% | +24.64% |
| Average volume | 146.81K | 43.46K |
| Shares outstanding | 42.12M | 6.51M |
| Employees | 205 | 613 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- SKIN has outperformed APYX by 831.7 percentage points over the past year.
- SkinHealth Systems is more profitable, keeping -3.2 cents of every revenue dollar as net income versus -21.2 cents for Apyx Medical.
- Apyx Medical grew revenue faster in its latest fiscal year (+9.86% vs -10.02%).
About Apyx Medical
APYX stock →Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM).
Health Care · Medical/Dental Instruments · 205 employees
About SkinHealth Systems
SKIN stock →SkinHealth Systems Inc., a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums.
Health Care · Medical/Dental Instruments · 613 employees
APYX vs SKIN FAQ
Which is bigger, Apyx Medical or SkinHealth Systems?
Apyx Medical (APYX) is larger, with a market capitalization of $101.10M compared with $76.68M for SkinHealth Systems (SKIN).
Which stock has performed better over the past year, APYX or SKIN?
SKIN returned +791.67% over the past 12 months, compared with -40.00% for APYX (price return, excluding dividends). Past performance does not predict future results.
Are Apyx Medical and SkinHealth Systems in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.